Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:
African American Hub News
 

Back to home » News & Views » Treatment News


 

December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007


emailrssprint

June 16, 2008

Scoring Tool Helps Predict KS Worsening

A simple scoring tool is able to predict which HIV-positive patients with the AIDS-related Kaposi’s sarcoma (KS) are most likely to see their cancer progress, according to a study published in the May 31 issue of AIDS, and reported by AIDSmap.

KS, which is caused by the human herpes virus-8 (HHV-8), was once a common skin cancer in people with HIV. Though antiretroviral (ARV) treatment is one of the most effective measures a person can take to keep KS at bay, a small percentage of people develop new lesions or worsening KS symptoms despite the use of ARV therapy. And until recently, there haven’t been any tools to help predict which HIV-positive people with KS are likely to respond well to ARV treatment alone or those who will require therapy specifically for their lesions.

In designing such a tool, Emmanuelle Boffi El Amari, MD, from the Geneva University Hospital in Switzerland, and her colleagues found three variables that increased the risk for KS disease progression, after conducting an analysis of stored blood samples from 144 patients diagnosed with KS in the Swiss HIV Cohort study.

The first variable was disease staging. As might be expected, those initially diagnosed with more widespread and aggressive symptoms, classified as disease stage T1, were five times more likely to have disease progression than those classified with the less severe disease stage T0.

Second, people with a CD4 count of less than 200 were twice as likely as people with a higher CD4 count to have KS progression. Third, people who had detectable levels of HHV-8 were also twice as likely to have KS progression as people with no detectable HHV-8.

Boffi El Amari’s team writes that going forward, physicians can give a score of two points to people with a disease stage of T1, and one point each to people with either a low CD4 count or detectable HHV-8 levels. People with a score of two or more would be most likely to have KS progression and thus, most likely to need KS chemotherapy.

NEW! Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

         


[Go to top]


Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Blogs by African-Americans
Antonia
Felipe
Jeanette
Pinnace
Kate
Ferguson

Read the blogs
Overheard in the Forums
"I'm HIV positive and diabetic (as well as have high cholesterol) and some of my meds specify taking them with 'high fat foods' which I have to do twice a day. I've eaten as healthy as possible, but when it comes to high fat foods, I am in a quandary...about what to eat sometimes..."

from Nutrition & HIV


Join the forums

Real Health Poll
Question: How would you characterize your stress level at work?
Minimally stressful
Moderately stressful
Extremely stressful

Smart + Strong Network
POZ Magazine
POZ Personals
POZ Mentor
POZ ASO Directory
AIDSmeds
Real Health Magazine
TuSalud Magazine
ComboCards
Rx Info Cards
Also visit POZ on...
Facebook

MySpace

YouTube

[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy